drug · antibody
patient view →obexelimab
Phase 3updated 2mo agoby $ZBIO Zenas BioPharma, Inc.🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 4 investigational indications.
targets
B-lymphocyte antigen CD19Low affinity immunoglobulin gamma Fc region receptor II-b
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that